Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_assertion description "[Endothelial monocyte activating polypeptide II (EMAP-II) is a tumor-derived cytokine with potent effects on endothelial cells in vitro and in vivo including upregulation of tissue factor and the sensitization of human melanoma to systemic TNF treatment via its effects on the tumor vasculature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_assertion evidence source_evidence_literature NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_assertion SIO_000772 10873516 NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_assertion wasDerivedFrom befree-20150227 NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_assertion wasGeneratedBy ECO_0000203 NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP390832.RA29x7O5rYFNu-aNm0-LGA8MoAN61l-ifzr2BnH0S7Rsc130_provenance.